Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functionality of immune cells in COVID-19 infection: development of cell-based therapeutics. | Bioimpacts | 2023 | 37193075 | PubTator, text mining | PubMed |
| Atlas of interactions between SARS-CoV-2 macromolecules and host proteins. | Cell Insight | 2023 | 37192911 | PubTator, text mining | PubMed |
| SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells. | Virus Res | 2023 | 37192725 | PubTator, text mining | PubMed |
| Structure-guided optimization of adenosine mimetics as selective and potent inhibitors of coronavirus nsp14 N7-methyltransferases. | Eur J Med Chem | 2023 | 37192550 | PubTator, text mining | PubMed |
| Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases. | Cell Commun Signal | 2023 | 37189112 | PubTator, text mining | PubMed |
| Immunology of SARS-CoV-2 infection and vaccination. | Clin Chim Acta | 2023 | 37187222 | PubTator, text mining | PubMed |
| Self-assembly coupled to liquid-liquid phase separation. | PLoS Comput Biol | 2023 | 37186597 | PubTator, text mining | PubMed |
| Preclinical evaluation of oncolytic potential human rotavirus Wt 1-5 in gastric adenocarcinoma. | PLoS One | 2023 | 37186587 | PubTator, text mining | PubMed |
| Unraveling the catalytic mechanism of SARS-CoV-2 papain-like protease with allosteric modulation of C270 mutation using multiscale computational approaches. | Chem Sci | 2023 | 37181765 | PubTator, text mining | PubMed |
| Looking into sewage: how far can metagenomics help to detect human enteric viruses? | Front Microbiol | 2023 | 37180249 | PubTator, text mining | PubMed |
| Improved understanding of biorisk for research involving microbial modification using annotated sequences of concern. | Front Bioeng Biotechnol | 2023 | 37180048 | PubTator, text mining | PubMed |
| COVID-19 Therapeutics: An Update on Effective Treatments Against Infection With SARS-CoV-2 Variants. | Immune Netw | 2023 | 37179752 | PubTator, text mining | PubMed |
| From Cell to Symptoms: The Role of SARS-CoV-2 Cytopathic Effects in the Pathogenesis of COVID-19 and Long COVID. | Int J Mol Sci | 2023 | 37175995 | PubTator, text mining | PubMed |
| Autophagy Receptor p62 Regulates SARS-CoV-2-Induced Inflammation in COVID-19. | Cells | 2023 | 37174682 | PubTator, text mining | PubMed |
| Accelerating antiviral drug discovery: lessons from COVID-19. | Nat Rev Drug Discov | 2023 | 37173515 | PubTator, text mining | PubMed |
| Marine drugs as putative inhibitors against non-structural proteins of SARS-CoV-2: an in silico study. | J Mol Model | 2023 | 37171714 | PubTator, text mining | PubMed |
| Integrated interactome and transcriptome analysis reveals key host factors critical for SARS-CoV-2 infection. | Virol Sin | 2023 | 37169126 | PubTator, text mining | PubMed |
| SABRes: in silico detection of drug resistance conferring mutations in subpopulations of SARS-CoV-2 genomes. | BMC Infect Dis | 2023 | 37158832 | PubTator, text mining | PubMed |
| Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection. | Front Immunol | 2023 | 37153606 | PubTator, text mining | PubMed |
| Design of novel pyrimidine based remdesivir analogues with dual target specificity for SARS CoV-2: A computational approach. | Int J Biol Macromol | 2023 | 37148943 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=22